Fig. 2: ROC curves for signatures predicting treatment outcome at 6 months ATT (TB treatment completed vs. treatment failure).

a Using baseline patient characteristics and/or transcriptional biomarkers. b Using 2-month patients characteristics and/or transcriptional biomarkers. c Using baseline patient characteristics and/or protein biomarkers. d Using 2-month patient characteristics and/or protein biomarkers.